ATE514677T1 - Als serotonintransporterinhibitoren und neurokinin-1-rezeptorantagonisten geeignete piperidinderivate - Google Patents

Als serotonintransporterinhibitoren und neurokinin-1-rezeptorantagonisten geeignete piperidinderivate

Info

Publication number
ATE514677T1
ATE514677T1 AT07727325T AT07727325T ATE514677T1 AT E514677 T1 ATE514677 T1 AT E514677T1 AT 07727325 T AT07727325 T AT 07727325T AT 07727325 T AT07727325 T AT 07727325T AT E514677 T1 ATE514677 T1 AT E514677T1
Authority
AT
Austria
Prior art keywords
serotonin transporter
neurokinin
receptor antagonists
treatment
inhibitors
Prior art date
Application number
AT07727325T
Other languages
English (en)
Inventor
Christophe Grundschober
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE514677T1 publication Critical patent/ATE514677T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT07727325T 2006-04-03 2007-03-26 Als serotonintransporterinhibitoren und neurokinin-1-rezeptorantagonisten geeignete piperidinderivate ATE514677T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112170 2006-04-03
PCT/EP2007/052852 WO2007113153A1 (en) 2006-04-03 2007-03-26 Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists

Publications (1)

Publication Number Publication Date
ATE514677T1 true ATE514677T1 (de) 2011-07-15

Family

ID=36923892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727325T ATE514677T1 (de) 2006-04-03 2007-03-26 Als serotonintransporterinhibitoren und neurokinin-1-rezeptorantagonisten geeignete piperidinderivate

Country Status (13)

Country Link
US (2) US7872022B2 (de)
EP (1) EP2004605B1 (de)
JP (1) JP5027208B2 (de)
KR (1) KR101101107B1 (de)
CN (1) CN101460460B (de)
AT (1) ATE514677T1 (de)
AU (1) AU2007233812B2 (de)
BR (1) BRPI0709742A2 (de)
CA (1) CA2648065C (de)
ES (1) ES2367219T3 (de)
IL (1) IL194392A (de)
MX (1) MX2008012634A (de)
WO (1) WO2007113153A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7872022B2 (en) * 2006-04-03 2011-01-18 Hoffmann-La Roche Inc. Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
TW202246215A (zh) * 2015-12-18 2022-12-01 美商亞德利克斯公司 作為非全身ｔｇｒ５促效劑之經取代之４－苯基吡啶化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98757A (en) 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
JP2001523245A (ja) 1997-04-24 2001-11-20 メルク シヤープ エンド ドーム リミテツド 肥満を治療するためのｎｋ−１受容体拮抗薬およびｓｓｒｉの使用
GB9904786D0 (en) * 1999-03-02 1999-04-28 Merck Sharp & Dohme Therapeutic agents
EP1035115B1 (de) 1999-02-24 2004-09-29 F. Hoffmann-La Roche Ag 4-Phenylpyridinderivate und deren Verwendung als NK-1 Rezeptorantagonisten
GB9924855D0 (en) 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
JP3860445B2 (ja) * 2001-04-19 2006-12-20 独立行政法人科学技術振興機構 Ｃｕ−Ｂｅ基非晶質合金
GB0119797D0 (en) 2001-08-14 2001-10-03 Glaxo Group Ltd Chemical compounds
KR100866220B1 (ko) * 2001-09-06 2008-10-30 가부시키가이샤 노리타케 캄파니 리미티드 도체 조성물 및 그 제조방법
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
JP3963802B2 (ja) * 2002-08-30 2007-08-22 独立行政法人科学技術振興機構 Ｃｕ基非晶質合金
KR100677805B1 (ko) * 2003-07-23 2007-02-02 샤프 가부시키가이샤 은 합금 재료, 회로 기판, 전자 장치 및 회로 기판의 제조방법
WO2005032464A2 (en) 2003-09-30 2005-04-14 Merck & Co., Inc. Phenyl pyrrolidine ether tachykinin receptor antagonists
KR100583230B1 (ko) * 2004-03-29 2006-05-25 한국과학기술연구원 구리계 비정질 합금 조성물
US7872022B2 (en) * 2006-04-03 2011-01-18 Hoffmann-La Roche Inc. Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
WO2008001518A1 (fr) * 2006-06-30 2008-01-03 Mitsubishi Materials Corporation Composition de fabrication d'une électrode dans une cellule solaire, procédé de fabrication de l'électrode, et cellule solaire utilisant une électrode obtenue par le procédé de fabrication
JPWO2008078374A1 (ja) * 2006-12-25 2010-04-15 ナミックス株式会社 太陽電池用導電性ペースト
US20080196794A1 (en) * 2007-02-20 2008-08-21 Centre National De La Recherche Scientifique Institut National Polytechnique De Grenoble Bulk metallic glass/metal composites produced by codeformation
US9580810B2 (en) * 2007-02-27 2017-02-28 Mitsubishi Materials Corporation Dispersion of metal nanoparticles, method for producing the same, and method for synthesizing metal nanoparticles
TWI423462B (zh) * 2008-10-22 2014-01-11 Ind Tech Res Inst 矽晶太陽電池之背面電極製造方法
KR101741683B1 (ko) * 2010-08-05 2017-05-31 삼성전자주식회사 도전성 페이스트, 상기 도전성 페이스트를 사용하여 형성된 전극을 포함하는 전자 소자 및 태양 전지
US8974703B2 (en) * 2010-10-27 2015-03-10 Samsung Electronics Co., Ltd. Conductive paste and electronic device and solar cell including an electrode formed using the same

Also Published As

Publication number Publication date
AU2007233812A1 (en) 2007-10-11
BRPI0709742A2 (pt) 2011-07-26
CN101460460B (zh) 2011-07-27
AU2007233812B2 (en) 2013-03-21
IL194392A (en) 2013-10-31
US20110105561A1 (en) 2011-05-05
EP2004605B1 (de) 2011-06-29
CA2648065C (en) 2015-06-02
CA2648065A1 (en) 2007-10-11
ES2367219T3 (es) 2011-10-31
US8580821B2 (en) 2013-11-12
KR101101107B1 (ko) 2012-01-03
KR20080100383A (ko) 2008-11-17
IL194392A0 (en) 2009-08-03
MX2008012634A (es) 2008-10-13
CN101460460A (zh) 2009-06-17
EP2004605A1 (de) 2008-12-24
US7872022B2 (en) 2011-01-18
US20070232652A1 (en) 2007-10-04
WO2007113153A1 (en) 2007-10-11
JP5027208B2 (ja) 2012-09-19
JP2009532409A (ja) 2009-09-10

Similar Documents

Publication Publication Date Title
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20091741L (no) Pyrazolinforbindelser som mineralkortikoidreceptorantagonister
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
NO20061137L (no) Cyklopropylderivater som NK3-reseptorantagonister
NO20083582L (no) Pyridin-2-karboksamide derivater
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
NO20071593L (no) Pyrimidinderivater
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
NO20091889L (no) Inhibitorer av spiroketon acetyl-CoA karboksylase
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
ATE475645T1 (de) Pyrrolidinderivate als doppelte nk1/nk3- rezeptorenantagonisten
NO20080445L (no) Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20084363L (no) 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister
NO20063597L (no) Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
DE602006010540D1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor
NO20080033L (no) Kinolinderivater som NK3-antagonister
ATE434605T1 (de) Inhibitoren des serotonintransporters (sert)
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2004605

Country of ref document: EP